Keywords: s-p, peg-intron, demand, difficulties, schering-plough, says, produce

S-P's PEG-Intron demand difficulties.

Article | 21 January 2002

Print This

Schering-Plough says it can not produce enough of its PEG-Intron(interferon alfa-2b) treatment for chronic hepatitis C to meet ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in